NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. We are currently focused on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity.
Frequently Asked Questions
When was NeuroOne incorporated?
We were originally incorporated in the state of Nevada on August 20, 2009 as Original Source Entertainment, Inc. We changed our name to NeuroOne Medical Technologies Corporation and reincorporated in Delaware before we entered into an agreement and plan of merger on July 20, 2017 to acquire NeuroOne, Inc., which was incorporated under the laws of the State of Delaware on October 7, 2016. The NeuroOne, Inc. predecessor entity, NeuroOne LLC, was formed on December 13, 2013 and operated as a limited liability company until it was merged with and into NeuroOne, Inc.
When is NeuroOne’s fiscal year end?
Who are NeuroOne’s independent auditors?
BDO USA LLP
Who is NeuroOne’s outside legal counsel?
Honigman Miller Schwartz and Cohn LLP
Can I buy stock directly from NeuroOne?
No, you will need to contact a licensed stock broker or use an online trading account
How do I get my purchased shares?
Contact Action Stock Transfer by telephone at (801) 274-1088 or by email at
What is NeurOne’s CUSIP number?
Who can I contact for general information about NeuroOne?
Email us at
Where is NeuroOne located?
7599 Anagram Drive, Eden Prairie, MN 55344